Correction to: Use of antibiotics in the early COVID‑19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic

Eur J Clin Pharmacol. 2024 Oct;80(10):1591. doi: 10.1007/s00228-024-03742-1.

Aleksandra Opalska^{1

2}, Helga Gardarsdottir^{1

3}, Marcel Kwa⁴, Jadwiga Wójkowska-Mach⁵, Monica Sabate^{6

7}, Maria Elena Ballarin^{6

7}, Mark de Groot⁸, Hubert Leufkens⁹

¹ Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands.
² Directorate‑General for Health and Food Safety, European Commission, Brussels, Belgium.
³ Department of Clinical Pharmacy, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, Netherlands.
⁴ Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, Netherlands.
⁵ Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Crakow, Poland.
⁶ Department of Clinical Pharmacology, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
⁷ Clinical Pharmacology Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
⁸ UPOD, Central Diagnostic Laboratory, Division Laboratories, Pharmacy and Biomedical Genetics, Utrecht, Netherlands.
⁹ Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. [email protected].

No abstract available

Publication types